58.1 F
Park Forest
Wednesday, August 10, 2022
Subscribe to eNews Park Forest

Bristol-Myers Squibb Initiates a Nationwide Voluntary Recall of Coumadin® 1 mg Tablet Blister Packs

Silver Spring, Maryland–(ENEWSPF)–July 13, 2010.  Bristol-Myers Squibb initiates a voluntary recall of 3 lots of physician sample blister packs of Coumadin® 1 mg tablets and 5 lots, of Coumadin 1 mg tablet hospital unit dose (HUD) blister packs. The following lot numbers are included in this recall: Physician Sample Blister Packs: Lot# 9A48931A, 9A48931B, 9A48931C, expiration January 2012; HUD Blister Pack: Lot# 8F34006B, 8K44272A, 8K46168A, 9F44437A and 9K58012B with expiry dates between June 2011 and November 2012. The recall is a precautionary measure based upon the company’s determination that some of the tablets, over time, may not meet specification for isopropanol. Isopropanol is used to maintain the active ingredient, Coumadin, in the crystalline state, and could affect the therapeutic levels of the active ingredient.

Coumadin is prescribed to treat or prevent blood clots. A decrease of active ingredient may increase the risk of clots which could lead to heart attack or stroke and if there is too much active ingredient, there is an increased risk of bleeding.

The recall only involves Coumadin 1 mg tablet blister-packs distributed in the U.S. This recall does not involve Coumadin 1 mg supplied in bottles or any other strengths and dosage forms of the product. Patients who may have product from the subject lots should contact their physicians to ensure that their anticoagulation therapy is not interrupted.

To date, the company has not received any reports of adverse events related to this issue. Bristol-Myers Squibb is committed to ensuring patient safety and is working to resolve this issue quickly and appropriately. The company has notified the U.S. Food and Drug Administration (FDA), and has issued recall communications to all physicians and other customers involved.

Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov.

Healthcare professionals and customers may call the following for assistance if they have further questions about the recall:

 

Recall Logistics Stericycle
1-877-546-0128
General Inquiries Bristol-Myers Squibb Customer Relations
1-800-332-2056 (option 1, then option 4)
Medical Inquiries Bristol-Myers Squibb Medical Information
1-800-321-1335 (option 5)
Recall Reimbursement Process Bristol-Myers Squibb Customer Service Operations
1-800-631-5244 (option 1, then option 5)

 

Source: fda.gov

Recent Articles

Stay Connected

3,827FansLike
1,274FollowersFollow
574SubscribersSubscribe

Local Advertisers

Prairie State College
Proud member of LION Publishers
Dining on the Green, Downtown Park Forest
DonnerHollen Construction

ENEWSPF NEWS ALERTS

Trending

Park Forest
clear sky
58.1 ° F
64.6 °
54.7 °
92 %
0mph
0 %
Wed
80 °
Thu
81 °
Fri
78 °
Sat
82 °
Sun
74 °

About Google Ads

The Google-supplied ads that appear on this website are not reviewed ahead of time and differ for each visitor. If anything offensive, inappropriate, or otherwise unwholesome appears, please notify us so we can take steps to block that specific advertiser. Email the URL or advertiser name to [email protected].